Related Experiment Video
Updated: Jan 17, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Targeted immunotherapies and nanomedicines for ovarian cancer: the way forward
Yue Li1,2, Juntong Dou1,2, Yannan Fu1,2
1Central Laboratory, Yanbian University Hospital, Yanji, China.
Abstract:
Ovarian cancer (OC) is the leading cause of death among gynecological cancers, with high mortality due to late diagnosis. Immunotherapy and nanomedicine show potential in targeting cancer cells and inducing immunogenic cell death. However, challenges like poor biodegradability and untargeted immune activation persist. Emerging solutions, including enhanced nanoparticles and personalized medicine, aim to improve efficacy while minimizing side effects by tailoring treatments to individual profiles and disease stages.
Insights
Ovarian cancer (OC) survival is poor due to late diagnosis. New nanomedicine and immunotherapy approaches show promise for targeted treatment and improved patient outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Immunotherapy
Background:
- Ovarian cancer (OC) is a leading cause of gynecological cancer mortality.
- Late diagnosis significantly contributes to the high mortality rates associated with OC.
- Current treatments face challenges including poor biodegradability and non-specific immune activation.
Purpose of the Study:
- To explore the potential of immunotherapy and nanomedicine in treating ovarian cancer.
- To address the limitations of existing therapeutic strategies for OC.
- To investigate emerging solutions for enhanced efficacy and reduced side effects in OC treatment.
Main Methods:
- Review of current literature on nanomedicine and immunotherapy for ovarian cancer.
- Analysis of challenges in biodegradability and immune activation.
- Exploration of enhanced nanoparticles and personalized medicine approaches.
Main Results:
- Immunotherapy and nanomedicine demonstrate potential for targeting OC cells.
- These approaches can induce immunogenic cell death, a key anti-cancer mechanism.
- Enhanced nanoparticles and personalized medicine offer solutions to overcome current therapeutic hurdles.
Conclusions:
- Advanced nanomedicine and immunotherapy hold promise for improving ovarian cancer treatment.
- Personalized medicine strategies are crucial for tailoring treatments to individual patient needs and disease characteristics.
- Further research into enhanced nanoparticles and targeted immune activation is warranted to improve OC survival rates.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

